We are proud to have won two prestigious honors at the Outsourced Pharma 2025 CDMO Leadership Awards — a recognition of BioDuro’s excellence in pharmaceutical development and manufacturing. These awards celebrate the top contract development and manufacturing organizations (CDMOs), as rated by customers who have worked with them over the past 24 months. BioDuro stood out globally, earning recognition in two key categories:
Small Molecule Active Pharmaceutical Ingredient (API) – Global
Small Molecule Dosage Form – Global
Among more than 200 CDMO companies evaluated, BioDuro was the only company named a winner in the Small Molecule Dosage Form – Global category — a rare distinction that highlights our leadership and commitment to quality.
“We are honored to receive this award,” said Jim Li, President, CMC at BioDuro. “This reflects our team’s dedication to innovation and exceptional service in drug development and manufacturing.”
With seven global campuses, BioDuro offers comprehensive, end-to-end services from preclinical development through commercial manufacturing — helping bring life-saving therapies to market faster.
The awards were presented at the Outsourced Pharma CDMO Leadership Awards Ceremony held on March 19 in New York City. BioDuro remains committed to being a trusted partner to pharmaceutical and biotech companies worldwide.
Home